Segall Bryant & Hamill’s AMERISAFE AMSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-8,777
Closed -$537K 708
2020
Q2
$537K Sell
8,777
-2,194
-20% -$137K 0.01% 572
2020
Q1
$708K Sell
10,971
-1,229
-10% -$80.6K 0.01% 511
2019
Q4
$806K Sell
12,200
-910
-7% -$60.3K 0.01% 563
2019
Q3
$866K Buy
13,110
+56
+0.4% +$3.71K 0.01% 546
2019
Q2
$832K Buy
13,054
+52
+0.4% +$3.11K 0.01% 563
2019
Q1
$772K Buy
13,002
+345
+3% +$20.5K 0.01% 588
2018
Q4
$718K Sell
12,657
-424
-3% -$26.4K 0.01% 581
2018
Q3
$810K Buy
13,081
+3,588
+38% +$224K 0.01% 587
2018
Q2
$548K Buy
+9,493
New +$554K 0.01% 658

Other funds holding AMSF

Segall Bryant & Hamill's AMSF Position: Q3 2020 in Review

Segall Bryant & Hamill sold out of AMERISAFE (AMSF) in Q3 2020, closing a stake of 8,777 shares — an estimated $537K sold.

Segall Bryant & Hamill first reported a position in AMSF in Q2 2018 and held it in 9 quarters. The position peaked at $866K in Q3 2019. 173 funds tracked by Wall St. Rank hold AMSF as of Q3 2020.

  • Segall Bryant & Hamill reported no remaining AMERISAFE position as of Q3 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 8,777 AMERISAFE shares in Q3 2020, an estimated $537K.
  • Segall Bryant & Hamill first reported a position in AMERISAFE in Q2 2018 and held it in 9 quarters.
  • Segall Bryant & Hamill's AMERISAFE position peaked at $866K in Q3 2019.
  • 173 funds tracked by Wall St. Rank held AMERISAFE as of Q3 2020.

Based on Segall Bryant & Hamill's 13F filing for Q3 2020, filed 13 Nov 2020.